Table 1 Clinicopathological data of the studied breast cancer cases (n = 135)
Variable | No. | % | |
|---|---|---|---|
Age | Min. – Max. | 30.0–82.0 | |
Mean ± SD. | 55.39 ± 11.73 | ||
Median (IQR) | 55.0 (48.0–65.0) | ||
Size | Min. – Max. | 0.50–15.0 | |
Mean ± SD. | 3.63 ± 2.20 | ||
Median (IQR) | 3.0 (2.0–5.0) | ||
T stage grouping | Early | 105 | 77.8 |
Advanced | 30 | 22.2 | |
Nodal metastasis | No | 31 | 23.0 |
Yes | 104 | 77.0 | |
AJCC stage grouping | Early | 63 | 46.7 |
Advanced | 72 | 53.3 | |
Distant metastasis | No | 121 | 89.6 |
Yes | 14 | 10.4 | |
Grade | Grade I | 2 | 1.5 |
Grade II | 113 | 83.7 | |
Grade III | 20 | 14.8 | |
Grade | Low grade | 115 | 85.2 |
High grade | 20 | 14.8 | |
Necrosis | Absent | 97 | 71.9 |
Present | 38 | 28.1 | |
Mitosis | Min. – Max. | 1.0–23.0 | |
Mean ± SD. | 3.90 ± 5.24 | ||
Median (IQR) | 1.0 (1.0–3.0) | ||
NPI score | Min. – Max. | 2.40–8.0 | |
Mean ± SD. | 5.11 ± 1.28 | ||
Median (IQR) | 5.20 (4.20–6.0) | ||
NPI group | Poor | 59 | 43.7 |
Moderate | 55 | 40.7 | |
Good | 21 | 15.6 | |
Tumor infiltrating lymphocytes | Absent | 48 | 35.6 |
Present | 87 | 64.4 | |
Lymphovascular invasion | No | 127 | 94.1 |
Yes | 8 | 5.9 | |
Grade of DCIS (no=74) | Low grade | 21 | 28.4 |
High grade | 53 | 71.6 | |
ER | Negative | 29 | 21.5 |
Positive | 106 | 78.5 | |
PR | Negative | 41 | 30.4 |
Positive | 94 | 69.6 | |
Her2neu | Negative | 84 | 62.2 |
Positive | 51 | 37.8 | |
Ki 67 proliferative index | Low | 79 | 58.5 |
High | 56 | 41.5 | |
Molecular subtype | Luminal | 106 | 78.5 |
Her2neu-enriched | 18 | 13.3 | |
Triple negative | 11 | 8.2 | |